The De-Escalate Trial: Atazanavir or Atazanavir/Ritonavir Substitution for Ritonavir Boosted PI Therapy in HIV-Infected Individuals Experiencing Ongoing HIV Viremia and Hyperlipidemia: A Randomized Controlled Pilot Study.

Trial Profile

The De-Escalate Trial: Atazanavir or Atazanavir/Ritonavir Substitution for Ritonavir Boosted PI Therapy in HIV-Infected Individuals Experiencing Ongoing HIV Viremia and Hyperlipidemia: A Randomized Controlled Pilot Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Jul 2011

At a glance

  • Drugs Atazanavir; HIV protease inhibitors; Ritonavir
  • Indications HIV infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms De-Escalate
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 May 2011 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 26 May 2011 Actual initiation date changed from Oct 2003 to Jan 2004 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top